###begin article-title 0
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Association of polymorphisms in APOE, p53, and p21 with primary open-angle glaucoma in Turkish patients
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 94 97 94 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 104 105 104 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 142 145 142 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
To investigate the association between Apolipoprotein E (APOE), tumor suppressor protein p53 (p53), and cyclin-dependent kinase inhibitor 1A (p21) genes and primary open-angle glaucoma (POAG) in a cohort of Turkish subjects.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 292 293 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 421 425 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 427 430 425 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 436 439 434 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 18 26 <span type="species:ncbi:9606">patients</span>
###xml 31 36 <span type="species:ncbi:9606">women</span>
###xml 41 44 <span type="species:ncbi:9606">men</span>
###xml 75 80 <span type="species:ncbi:9606">women</span>
###xml 85 88 <span type="species:ncbi:9606">men</span>
###xml 259 267 <span type="species:ncbi:9606">patients</span>
Seventy-five POAG patients (49 women, 26 men) and 119 healthy subjects (67 women, 52 men) were genotyped with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Allele and genotype frequencies between healthy subjects and glaucoma patients were compared by the chi2 test, and intraocular pressure (IOP), cup/disc ratio (C/D) and visual field indices (MD and PSD) were compared among different APOE, p53, and p21 genotypes in POAG group. A p value <0.05 was considered as statistically significant.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 164 173 160 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE, p53</italic>
###xml 179 182 175 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 382 385 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 390 393 386 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 231 239 <span type="species:ncbi:9606">patients</span>
The mean ages were 63.8+/-9.5 and 61.8+/-10.2 years in POAG and control groups, respectively (p=0.18). There were no significant differences in the distribution of APOE, p53, and p21 genotypes between the healthy subjects and POAG patients (p=0.38, p=0.12, and p=0.2, respectively). There were no significant differences in maximum IOP, MD, and PSD values among different groups of p53 and p21 genotypes (p>0.05). POAG subjects with the epsilon2epsilon3 genotype had a worse PSD value (median=2.2) than those with the epsilon3epsilon4 genotype (median=1.77; p=0.01) and POAG subjects with the epsilon3epsilon3 genotype had worse MD and PSD values (median= -7.4 and 3.4, respectively) than those with the epsilon3epsilon4 genotype (median= -4.1 and 1.77, respectively; p=0.034 and 0.028, respectively).
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 49 58 49 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE, p53</italic>
###xml 64 67 64 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Our study found no link between polymorphisms in APOE, p53, and p21 genes and POAG in Turkish patients, although a larger sample is required to elucidate the role of these polymorphisms in the pathogenesis and course of glaucoma.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 532 533 532 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 751 756 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLC1A</italic>
###xml 766 772 766 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, MYOC</italic>
###xml 775 780 775 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLC1E</italic>
###xml 794 798 794 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 801 806 801 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLC1G</italic>
###xml 829 834 829 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 841 846 841 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLC3A</italic>
###xml 848 874 848 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cytochrome P4501B1, CYP1B1</italic>
###xml 901 902 901 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 903 904 903 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 473 479 <span type="species:ncbi:9606">people</span>
Glaucoma is a degenerative optic neuropathy, characterized by optic nerve head (ONH) changes and visual field loss. Elevated intraocular pressure (IOP) is generally accepted as the major modifiable risk factor for glaucoma, however, factors other than IOP also play role in the pathogenesis and progression of glaucoma, particularly in subjects with normal tension glaucoma (NTG). It is the second leading cause of blindness worldwide, estimated to affect about 70 million people, with 6.7 million of these being bilaterally blind [1]. Primary open-angle glaucoma (POAG, OMIM ) is the major type of primary glaucoma in most populations. POAG is a genetically heterogeneous disorder and at least 22 genetic loci have been mapped for POAG of which only GLC1A (myocilin, MYOC), GLC1E (optineurin, OPTN), GLC1G (WD repeat domain 36, WDR36), and GLC3A (cytochrome P4501B1, CYP1B1) have been characterized [2-7]. However, mutations in these genes account for less than 10% of POAG cases. It appears that POAG is a complex trait and multiple genes, each with allelic variations, and environmental factors contribute to the pathogenesis and phenotype and increase individual's susceptibility to glaucomatous optic neuropathy, with no particular gene having a single dominant effect.
###end p 10
###begin p 11
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 529 530 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 531 533 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 601 603 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 604 606 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 788 790 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1043 1045 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 1232 1234 1208 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 1235 1237 1211 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 1485 1487 1455 1457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 1488 1490 1458 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 1491 1493 1461 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1533 1535 1503 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 1536 1538 1506 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 616 619 <span type="species:ncbi:10116">rat</span>
###xml 1033 1041 <span type="species:ncbi:9606">patients</span>
Apolipoprotein E (APOE), which is the major apolipoprotein in the central nervous system, plays an important role in neural function and repair after injury. APOE is up-regulated in response to oxidative stress and is endowed with antioxidant properties [8]. It exists as three common isoforms E2, E3 and E4, encoded by different alleles (epsilon2, epsilon3, and epsilon4) on a single gene on chromosome 19 (OMIM ). Possession of the epsilon4 allele was shown to be associated with a reduced outcome after traumatic head injury [9,10] and increased risk of earlier development of Alzheimer's disease [11,12]. In the rat eye, it has been shown to be synthesized by Muller cells, secreted in the vitreous, absorbed by the retinal ganglion cells (RGC), and transported down the optic nerve [13]. Its possible role in RGC metabolism, together with its documented effect on neuronal survival following ischemic and traumatic insults, has led to the hypothesis that particular APOE isoforms could be related to neuronal damage in glaucoma patients [14]. Given the potential similarities between the cellular events leading to degeneration in both Alzheimer's disease and glaucoma, the higher incidence of glaucoma in Alzheimer's disease [15,16] and APOE epsilon4 allele as a risk factor for Alzheimer's disease, APOE seems to be a pliable candidate for glaucoma susceptibility. In the literature, some of the studies showed an association between certain types of APOE alleles and glaucoma [14,17-21], whereas others found no association [22-25].
###end p 11
###begin p 12
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 456 459 456 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bax</italic>
###xml 518 523 518 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bcl-2</italic>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 733 736 733 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 961 963 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 1024 1027 1024 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1092 1094 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 1129 1132 1129 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1172 1174 1172 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 1175 1177 1175 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 347 353 <span type="species:ncbi:9606">humans</span>
###xml 773 778 <span type="species:ncbi:9606">human</span>
Apoptosis is a form of genetically controlled, programmed cell death and an important mechanism responsible for RGC death in glaucoma [26,27]. One of the primary regulatory steps of apoptosis is the activation of the tumor suppressor protein, p53, which is encoded by the TP53 gene (guardian of the cell) located on the short arm of  (17p13.1) in humans. p53 functions as a transcription factor that can upregulate the expression of the pro-apoptotic gene bax and downregulate the expression of the antiapoptotic gene bcl-2. This protein has been described as "the guardian of the ," "the guardian angel gene," and the "master watchman," referring to its role in conserving stability by preventing genome mutation [28]. Mutations of p53 have been detected in almost 50% of human malignancies, since the mutant or inactivated p53 protein fails to initiate the apoptotic process and, consequently, genetically damaged cells proliferate in an uncontrolled manner [29]. In neurodegenerative processes and toxic neuronal injury, p53 is upregulated, thereby promoting cell death through apoptosis [30]. Genetic polymorphic variants of p53 were shown to be associated with POAG [31,32].
###end p 12
###begin p 13
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN1A</italic>
###xml 151 152 151 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 315 318 315 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 327 330 327 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 413 416 413 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 741 744 741 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 911 913 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 71 77 <span type="species:ncbi:9606">humans</span>
###xml 163 168 <span type="species:ncbi:9606">human</span>
Cyclin-dependent kinase (CdK) inhibitor 1A (p21, Cip1), is a  which in humans is encoded by the CDKN1A located on . It is known to cause irreversible G1 arrest in human fibroblasts by mediating the inhibition of CdKs [33]. p21 is the major transcriptional target of p53; despite this, loss-of-function mutations in p21 (unlike p53) do not predispose to cancer incidence. A single nucleotide polymorphism (SNP) in p21 which consists of a C to A transverse change at the third base of codon 31, resulting in the exchange of a Serine for an Arginine, has been reported [34]. This codon 31 polymorphism is thought to encode a DNA-binding zinc-finger domain [35]. A study on a Chinese population showed an association between the Arg form of the p21 codon 31 polymorphism and POAG, suggesting that this allele may alter the state of apoptosis in glaucomatous optic neuropathy, failing to protect the ganglion cells [36].
###end p 13
###begin p 14
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 68 71 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
In the present study, we evaluated the genetic association of APOE, p53, and p21 polymorphisms with POAG in a group of Turkish subjects and investigated their possible involvement with the disease phenotype and severity.
###end p 14
###begin title 15
Methods
###end title 15
###begin p 16
###xml 465 473 <span type="species:ncbi:9606">Patients</span>
###xml 794 802 <span type="species:ncbi:9606">patients</span>
The cases enrolled in this study were unrelated to each other and were derived exclusively from the Turkish population. All subjects have undergone systematic examination of optic disc, visual field examination with automated static white on white threshold perimetry using the 30-2/24-2 program of the Humphrey Field Analyzer (Dublin, CA), and IOP measurement with Goldmann applanation tonometry. Gonioscopy was utilized to confirm that all cases had open angles. Patients were classified as having POAG based on ONH or retinal nerve fiber layer () structural abnormalities. The subjects were excluded if they had congenital glaucoma or secondary causes (such as pigment dispersion, pseudoexfoliation, trauma, uveitis, or steroid induced glaucoma) for glaucoma. The control group consisted of patients who attended the ophthalmology clinic for refractive errors, routine ophthalmic examination, or medical staff with no ocular problems. They had no family history of glaucoma and their IOP measurements were <21 mmHg on 2 different visits.
###end p 16
###begin p 17
The study protocol was in adherence to the tenets of the Declaration of Helsinki and approved by the Ethics Committee of Hacettepe University School of Medicine. Informed consent was obtained from all study subjects after explanation of the nature and possible consequences of the study.
###end p 17
###begin title 18
Genetic analysis
###end title 18
###begin p 19
###xml 232 241 226 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE, p53</italic>
###xml 247 250 241 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
Venous blood was obtained from the subjects and stored at -20 degreesC for less than three months before DNA extraction. Genomic DNA was isolated from peripheral blood using the phenol-chloroform extraction method. The genotypes of APOE, p53, and p21 polymorphisms were determined by the PCR-RFLP method.
###end p 19
###begin p 20
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 418 426 412 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3</italic>
###xml 427 435 415 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3</italic>
###xml 437 445 419 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;2</italic>
###xml 446 454 422 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3</italic>
###xml 456 464 426 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3</italic>
###xml 465 473 429 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4</italic>
###xml 475 483 433 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;2</italic>
###xml 484 492 436 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4</italic>
###xml 498 506 444 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4</italic>
###xml 507 515 447 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4</italic>
APOE gene polymorphisms were investigated using the primer sequences 5'-GAA CAA CTG ACC CCG GTG GCG-3' (forward) and 5'-GGA TGG CGC TGA GGC CGC GCT-3' (reverse). PCR products were checked in 1.5% agarose gel. For RFLP analysis, PCR product was digested with HhaI at 37 degreesC overnight. Digested DNA fragments were separated on 10% polyacrylamide gel electrophoresis and five different APOE genotypes were observed (epsilon3/epsilon3, epsilon2/epsilon3, epsilon3/epsilon4, epsilon2/epsilon4, and epsilon4/epsilon4).
###end p 20
###begin p 21
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 355 358 349 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
For p53 gene polymorphisms, PCR was performed using the primer sequences 5'-CCT GAA AAC AAC GTT CTG GTA A-3' (forward) and 5'-GCA TTG AAG TCT CAT GGA AG-3' (reverse) [32]. For RFLP analysis, PCR product was digested with BstUI at 37 degreesC overnight. Digested DNA fragments were separated on 1.5% agarose gel electrophoresis. Amplified PCR products for p53 with a C nucleotide at codon 72 (Pro residue) remained undigested and were 448 bp or 432 bp in length depending on whether the 16 bp insertion was present or not. Products with a G nucleotide at codon 72 (Arg residue) were 248 or 232 bp in length depending whether the 16 bp insertion was present or not.
###end p 21
###begin p 22
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
For p21 gene polymorphisms, PCR was performed using the primer sequences 5'-GTC AGA ACC GGC TGG GGA TG-3' (forward) and 5'-CTC CTC CCA ACT CAT CCC GG-3' (reverse) [37]. For RFLP analysis, PCR product was digested with BlpI at 37 degreesC overnight. Digested DNA fragments were separated on 3% agarose gel electrophoresis. The Ser allele has a single BlpI restriction site (GCTNAGC), resulting in two fragments of 89 bp and 183 bp and the Arg allele remains undigested, producing a single band of 272 bp.
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 124 125 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 232 233 228 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 403 407 399 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 409 412 405 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 418 421 414 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
Genotypic distributions were examined for significant deviation from the Hardy-Weinberg equilibrium by a goodness of fit chi2 test. The frequencies of genotypes and alleles were compared among glaucoma and healthy subjects using chi2 test, whereas non-parametric Kruskal-Wallis and Mann-Whitney U tests were used to evaluate the differences in maximum IOP, cup/disc ratio (C/D), MD and PSD values among APOE, p53, and p21 genotypes in POAG group and p<0.05 was considered as statistically significant.
###end p 24
###begin title 25
Results
###end title 25
###begin p 26
###xml 430 437 416 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 437 438 423 424 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 628 632 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 634 637 620 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 643 646 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 801 818 787 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3/&#949;3</italic>
###xml 820 837 794 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;2/&#949;3</italic>
###xml 839 856 801 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3/&#949;4</italic>
###xml 858 875 808 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;2/&#949;4</italic>
###xml 881 898 819 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4/&#949;4</italic>
###xml 936 958 862 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;3/&#949;3</italic>
###xml 1059 1076 973 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;2/&#949;2</italic>
###xml 1124 1141 1026 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;2/&#949;4</italic>
###xml 1146 1163 1036 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4/&#949;4</italic>
###xml 1290 1297 1168 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 18 26 <span type="species:ncbi:9606">patients</span>
###xml 31 36 <span type="species:ncbi:9606">women</span>
###xml 41 44 <span type="species:ncbi:9606">men</span>
###xml 75 80 <span type="species:ncbi:9606">women</span>
###xml 85 88 <span type="species:ncbi:9606">men</span>
###xml 695 703 <span type="species:ncbi:9606">patients</span>
Seventy-five POAG patients (49 women, 26 men) and 119 healthy subjects (67 women, 52 men) were included in the study. The mean ages were 63.8+/-9.5 and 61.8+/-10.2 years in POAG and control groups, respectively (p=0.18). In POAG group, the mean+/-standard deviations (SD) of the IOP, C/D, MD and PSD were 26.8+/-3.5 mmHg, 0.6+/-0.2, 9.7+/-7.7 dB, and 5.2+/-4 dB, respectively. The distribution of genotypes was given in detail in Table 1. The observed genotypes did not show deviation from the Hardy-Weinberg equilibrium in either the cases or the controls (p>0.05). There were no significant differences in the distribution of APOE, p53, and p21 genotypes between the healthy subjects and POAG patients (p=0.39, p=0.12, and p=0.28 respectively). For the exon 4 polymorphism, five genotypes including epsilon3/epsilon3, epsilon2/epsilon3, epsilon3/epsilon4, epsilon2/epsilon4, and epsilon4/epsilon4 were observed in our study subjects. APOE epsilon3/epsilon3 was the most common genotype observed both in the glaucoma and the control groups, whereas genotype epsilon2/epsilon2 was not detected in both groups. The genotypes epsilon2/epsilon4 and epsilon4/epsilon4 were rare both in POAG and control groups. APOE allele frequencies also did not differ among POAG and control groups (p=0.14; Table 1).
###end p 26
###begin title 27
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 6 9 6 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
APOE, p53, and p21 genotype and allelic frequencies.
###end title 27
###begin p 28
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53,</italic>
###xml 204 207 204 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 256 264 <span type="species:ncbi:9606">patients</span>
The observed genotypes did not show deviation from the Hardy-Weinberg equilibrium in either the cases or the controls (p>0.05). There were no significant differences in the distribution of APOE, p53, and p21 genotypes between the healthy subjects and POAG patients.
###end p 28
###begin p 29
###xml 99 102 99 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 107 110 107 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 122 129 122 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 189 205 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;2&#949;3</italic>
###xml 210 226 198 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3&#949;3</italic>
###xml 306 322 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;2&#949;3</italic>
###xml 400 416 364 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3&#949;4</italic>
###xml 479 495 431 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3&#949;3</italic>
###xml 590 606 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3&#949;4</italic>
###xml 713 729 641 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;2&#949;4</italic>
###xml 823 839 739 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4&#949;4</italic>
There were no significant differences in maximum IOP, MD, and PSD values among different groups of p53 and p21 genotypes (Table 2). For APOE polymorphisms, these parameters were similar in epsilon2epsilon3 and epsilon3epsilon3, with no statistically significant differences, whereas POAG subjects with the epsilon2epsilon3 genotype had worse visual field defects (median PSD=2.2) than those with the epsilon3epsilon4 genotype (median PSD=1.77; p=0.01) and POAG subjects with the epsilon3epsilon3 genotype had worse MD and PSD values (median= -7.4 and 3.4, respectively) than those with the epsilon3epsilon4 genotype (median= -4.1 and 1.77, respectively; p=0.034 and 0.028, respectively). Only one subject had the epsilon2epsilon4 genotype and he had very advanced glaucoma and one subject with early stage glaucoma had the epsilon4epsilon4 genotype.
###end p 29
###begin title 30
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 89 92 89 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
Maximum IOP, Cup-Disc Ratio, MD, and PSD values among different groups of APOE, p53, and p21 genotypes.
###end title 30
###begin p 31
###xml 414 417 412 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 422 425 420 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Details of clinical features of 75 POAG patients and 119 unaffected controls for each genotype are shown in the table. IOP indicates maximum intraocular pressure; C/D indicates cup-disc ratio of optic nerve; MD and PSD indicate visual field indices and mean+/-SD (median) indicates standard deviation from the mean. There were no significant differences in maximum IOP, MD and PSD values among different groups of p53 and p21 genotypes. POAG subjects with epsilon2epsilon3 genotype had worse visual field defects and POAG subjects with epsilon3epsilon3 genotypes had worse MD and PSD values.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
Glaucoma is a neurodegenerative disease with multiple genes contributing to the pathogenesis, clinical features and response to treatment. Genetic association studies defining susceptibility to POAG may provide important insights into the pathogenesis, but should be treated with caution until the findings are independently replicated.
###end p 33
###begin p 34
###xml 118 128 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3/3</italic>
###xml 215 223 209 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3</italic>
###xml 365 369 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 369 377 357 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4</italic>
###xml 470 486 452 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;2&#949;3</italic>
###xml 491 507 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3&#949;3</italic>
###xml 579 595 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3&#949;4</italic>
###xml 626 628 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 644 646 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 672 674 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 836 838 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 884 892 830 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3</italic>
###xml 974 978 914 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 978 986 918 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4</italic>
###xml 1119 1121 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 1171 1175 1105 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 1175 1183 1109 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3</italic>
###xml 1188 1196 1116 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4</italic>
###xml 1525 1527 1447 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 1530 1538 1452 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;2</italic>
###xml 1540 1548 1456 1458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3</italic>
###xml 1554 1562 1464 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4</italic>
###xml 1776 1778 1680 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 1850 1863 1754 1761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;2</italic>
###xml 1911 1913 1809 1811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 1931 1944 1829 1836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4</italic>
###xml 2042 2044 1934 1936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 2068 2081 1960 1967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4</italic>
###xml 2158 2171 2044 2051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;2</italic>
###xml 2295 2297 2175 2177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 2344 2357 2224 2231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;2</italic>
###xml 2362 2370 2236 2238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4</italic>
###xml 2426 2428 2294 2296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 2459 2467 2327 2329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4</italic>
###xml 2582 2590 2444 2446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4</italic>
###xml 2642 2644 2498 2500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 2647 2651 2503 2507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 2651 2659 2507 2509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4</italic>
###xml 154 162 <span type="species:ncbi:9606">patients</span>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
###xml 1368 1376 <span type="species:ncbi:9606">patients</span>
###xml 1701 1709 <span type="species:ncbi:9606">patients</span>
###xml 1881 1889 <span type="species:ncbi:9606">patients</span>
###xml 2391 2399 <span type="species:ncbi:9606">patients</span>
###xml 2478 2486 <span type="species:ncbi:9606">patients</span>
In this study, we could not show an association between APOE genotypes/alleles and POAG. The most common genotype was epsilon3/3 observed in 70.7% of our patients with POAG and 73.9% of the control subjects and the epsilon3 allele was observed in 84% of patients with POAG and 85.7% of control subjects, which were not statistically different. The frequency of the APOEepsilon4 allele in our control and POAG groups were 10.1% and 7.3%, respectively. POAG subjects with epsilon2epsilon3 and epsilon3epsilon3 genotypes had worse visual field results compared to subjects with the epsilon3epsilon4 genotype. Ressiniotis et al. [22], Lake et al. [23], and Zetterberg et al. [24] have shown that the APOE genotype or alleles do not constitute a risk factor for POAG and NTG, comparable with our results. In the study of Ressiniotis et al. [22] in English population, the frequency of the epsilon3 allele was 72.6% in POAG group and 76% in control group and the frequency of the APOEepsilon4 allele in their control population was 13.3%, which was not different than the glaucoma group (14.6%). In their study, Lake et al. [23] found no significant difference in frequency of APOEepsilon3 and epsilon4 alleles between the normal tension glaucoma group (73.9% and 17.1%, respectively) and the control population (76.5% and 15.5%, respectively). In addition, comparing those patients with progressive NTG disease to the controls revealed no association between APOE genotype and the disease progression. In the study of Jia et al. [25], epsilon2, epsilon3, and epsilon4 frequencies were found to be 8.75%, 82.25% and 9%, respectively, in Northern Chinese, which were not statistically different between POAG patients and control group. In contrast to these studies, Junemann et al. [17] have shown a significant association between the level of IOP and the APOE epsilon2 allele in German patients, and Vickers et al. [14] showed that the APOE epsilon4 allele was associated with elevated risk for NTG in the Tasmanian population. In a recent study [18], the frequency of the APOE epsilon4 allele in POAG group was significantly higher, whereas the frequency of the APOE epsilon2 allele was found to be significantly lower than those in control group in Chinese population. In contrary, Mabuchi et al. [19] found a significantly lower frequency of the APOE epsilon2 and epsilon4 alleles in Japanese patients with OAG, and Lam et al. [20] found lower frequency of the epsilon4 allele in patients with NTG, but not with high tension glaucoma in Chinese, indicating a protective effect of the epsilon4 allele against glaucoma. In a study by Fan et al. [21], APOEepsilon4 carriers were found to have a decreased NTG risk (p=0.007).
###end p 34
###begin p 35
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 615 619 615 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 652 656 652 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
As shown above, there is no consensus whether APOE alleles constitute a risk factor or are protective against glaucoma. There are several possible explanations for these discrepancies [19]. APOE might have a more obvious effect in populations exposed to different environmental factors or with a different genetic background. The prevalence of NTG, which has a different pathogenesis than POAG is much higher in the Japanese population compared to others. In a previous study, the APOE -219G and -491T have been shown to affect optic nerve damage and visual field loss in glaucoma, which supports the importance of APOE expression and interaction with MYOC polymorphisms in the disease pathogenesis [38]. However, this association was not confirmed in the following studies done in Northern China [25], Southern China [20,21], and in England [39].
###end p 35
###begin p 36
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 339 342 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
###xml 443 446 443 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 726 729 726 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 1090 1092 1090 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 1142 1144 1142 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 1161 1164 1161 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 787 795 <span type="species:ncbi:9606">patients</span>
Previously, a specific functional polymorphism in exon 4 of p53 (Arg72Pro) was shown to alter its ability to induce apoptosis in vitro, with the Arg72 variant having enhanced apoptotic potential [40]. As the death of RGC in glaucoma has been proved to be way of apoptosis, many investigators examined whether common sequence variations in p53 are associated with POAG [26,27,41]. In two separate populations, different polymorphic variants in p53, codon 72, were shown to be associated with POAG, the arginine form being a risk factor in the British population [32], and the proline form in Chinese population with an odds ratio of 2.4 [31]. In this study, we did not observe any significant difference in the distribution of p53 codon 72 polymorphism between the control group and POAG patients, which is consistent with the results of Acharya et al. [42] and Dimasi et al. [43]. In the Indian population, the genotype distribution was 26.8%, 50.9%, and 22.3% for Arg homozygote, Pro/Arg heterozygote and Pro homozygote, respectively, whereas 34.3%, 44.8% and 20.9% in the glaucoma group [42]. In the white Australian cohort, Dimasi et al. [43] found that the p53 codon 72 Arg/Pro polymorphism was associated neither with the development of glaucoma (high or normal tension) nor with phenotype characteristics like age of onset or severity of glaucoma.
###end p 36
###begin p 37
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53.</italic>
###xml 148 151 148 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 481 484 481 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 669 672 669 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 753 755 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 411 417 <span type="species:ncbi:9606">people</span>
###xml 533 541 <span type="species:ncbi:9606">patients</span>
DNA insult can cause activation of p21, either directly or through transactivation by wild type p53. Cancer research has revealed that mutations of p21 are very rare and that SNPs are more likely to have a functional effect. The distribution of the p21 codon 31 polymorphism differs among different ethnic groups with a frequency of the Arg allele ranging from 4% in the white population [35] to 50% in Chinese people [44]. Tsai et al. [36] demonstrated that the Arg allele of the p21 codon 31 polymorphism was more frequent in POAG patients (56%) compared to healthy individuals (36%) in the Chinese population. In our study, we could not find any association between p21 codon 31 polymorphism and POAG, consistent with the study of Ressiniotis et al [37]. Arg allele was found in 8% of our control group and 13% in the POAG group. In the study of Ressiniotis et al [37] the distribution of the genotypes in the control subjects was 61 (83.6%) Ser homozygotes and 12 (16.4%) Ser/Arg heterozygotes, which was exactly the same with our control group.
###end p 37
###begin p 38
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 116 119 116 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 125 128 125 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 242 247 <span type="species:ncbi:9606">human</span>
The pathogenesis and genetic risk factors for glaucoma are not fully understood yet. Genetic polymorphisms in APOE, p53, and p21 have been investigated in several studies in different populations. Polymorphisms have important implications in human genetic studies and screening for such alleles helps in the detection of a genetic predisposition to disease. However, there are conflicting results about the association of these polymorphisms with glaucoma development and phenotype. The main problem in identifying the gene variants associated with susceptibility to common diseases is that the observed results are not replicated in subsequent studies that used different populations and/or larger numbers of cases versus controls. This discrepancy in the literature may reflect sampling bias, as some of the studies have small number of subjects or it could be attributed to ethnic disparity. Also in glaucoma studies, the inclusion of a normotensive glaucoma group, which has risk factors other than elevated IOP and therefore has a different etiopathogenesis, may make a study more sensitive to underlying neurodegenerative risk factors.
###end p 38
###begin p 39
###xml 172 181 172 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE, p53</italic>
###xml 187 190 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
This is the first population study in Turkish POAG patients for multiple polymorphisms that might be associated with POAG. Our study found no link between polymorphisms in APOE, p53, and p21 and POAG in Turkish subjects, although a larger sample is required to clarify the role of these polymorphisms in the pathogenesis and course of glaucoma if their effects are mild.
###end p 39
###begin title 40
Acknowledgments
###end title 40
###begin p 41
This research was funded by Scientific Research Fund of Hacettepe University ( BAP Project No: 0401601001). The authors thank Murat Yilmaz and Umut Arslan, Ph.D., in the Hacettepe University for help with statistical analysis and Gunkut Akar for help with genetic analysis.
###end p 41
###begin title 42
References
###end title 42
###begin article-title 43
###xml 10 16 <span type="species:ncbi:9606">people</span>
Number of people with glaucoma worldwide.
###end article-title 43
###begin article-title 44
Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (buphthalmos) in families linked to the GLC3A locus on chromosome 2p21.
###end article-title 44
###begin article-title 45
Identification of a gene that causes primary open angle glaucoma.
###end article-title 45
###begin article-title 46
Heredity in primary open-angle glaucoma.
###end article-title 46
###begin article-title 47
Adult-onset primary open-angle glaucoma caused by mutations in optineurin.
###end article-title 47
###begin article-title 48
Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1.
###end article-title 48
###begin article-title 49
Gene mapping for primary open angle glaucoma.
###end article-title 49
###begin article-title 50
Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides.
###end article-title 50
###begin article-title 51
Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury.
###end article-title 51
###begin article-title 52
Association of apolipoprotein E polymorphism with outcome after head injury.
###end article-title 52
###begin article-title 53
The role of Apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.
###end article-title 53
###begin article-title 54
Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.
###end article-title 54
###begin article-title 55
Apolipoprotein E is synthesized in the retina by Muller glial cells, secreted into the vitreous, and rapidly transported into the optic nerve by retinal ganglion cells.
###end article-title 55
###begin article-title 56
The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma.
###end article-title 56
###begin article-title 57
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Severe progression of glaucomatous optic neuropathy in patients with Alzheimer's disease.
###end article-title 57
###begin article-title 58
Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease.
###end article-title 58
###begin article-title 59
Prospective case control study on genetic assocation of apolipoprotein epsilon2 with intraocular pressure.
###end article-title 59
###begin article-title 60
A study on the association of apolipoprotein E genotypes with primary open-angle glaucoma and primary angle-closure glaucoma in northeast of China Chinese. [Article in Chinese]
###end article-title 60
###begin article-title 61
The apolipoprotein E gene polymorphism is associated with open angle glaucoma in the Japanese population.
###end article-title 61
###begin article-title 62
Association of apolipoprotein E polymorphisms with normal tension glaucoma in a Chinese population.
###end article-title 62
###begin article-title 63
###xml 106 114 <span type="species:ncbi:9606">patients</span>
SNPs and interaction analyses of myocilin, optineurin and apolipoprotein E in primary open angle glaucoma patients.
###end article-title 63
###begin article-title 64
The role of apolipoprotein E gene polymorphisms in primary open angle glaucoma.
###end article-title 64
###begin article-title 65
Normal tension glaucoma is not associated with the common apolipoprotein E gene polymorphisms.
###end article-title 65
###begin article-title 66
###xml 34 42 <span type="species:ncbi:9606">patients</span>
Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma.
###end article-title 66
###begin article-title 67
Multiple gene polymorphisms analysis revealed a different profile of genetic polymorphisms of primary open-angle glaucoma in northern Chinese.
###end article-title 67
###begin article-title 68
Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death.
###end article-title 68
###begin article-title 69
Ganglion cell death in glaucoma: what do we really know?
###end article-title 69
###begin article-title 70
Molecular genetics of lung cancer.
###end article-title 70
###begin article-title 71
p53-dependent cell death signaling in neurons.
###end article-title 71
###begin article-title 72
Distributions of p53 codon 72 polymorphism in primary open angle glaucoma.
###end article-title 72
###begin article-title 73
Primary open angle glaucoma is associated with a specific p53 gene haplotype.
###end article-title 73
###begin article-title 74
Lack of evidence of association of p21WAFI/CIPI polymorphism with lung cancer susceptibility and prognosis in Taiwan.
###end article-title 74
###begin article-title 75
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Molecular cloning, sequencing, chromosomal localization and expression of mouse p21.
###end article-title 75
###begin article-title 76
###xml 64 69 <span type="species:ncbi:9606">human</span>
Mutational analysis of the p21/WAF1/ CIP1/SID1 coding region in human tumour cell lines.
###end article-title 76
###begin article-title 77
A codon 31ser-arg polymorphism of the WAF-1/CIP-1/p21/tumour suppressor gene in Chinese primary open-angle glaucoma.
###end article-title 77
###begin article-title 78
A polymorphism at codon 31 of gene p21 is not associated with primary open angle glaucoma in Caucasians.
###end article-title 78
###begin article-title 79
Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene.
###end article-title 79
###begin article-title 80
Apolipoprotein E promoter polymorphisms do not have a major influence on the risk of developing primary open angle glaucoma.
###end article-title 80
###begin article-title 81
I-Ju Leu J, Della Pietra AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential.
###end article-title 81
###begin article-title 82
Glaucoma, apoptosis, and neuroprotection.
###end article-title 82
###begin article-title 83
###xml 80 88 <span type="species:ncbi:9606">patients</span>
Distribution of p53 codon 72 polymorphism in Indian primary open angle glaucoma patients.
###end article-title 83
###begin article-title 84
Lack of association of p53 polymorphisms and haplotypes in high and normal tension open angle glaucoma.
###end article-title 84
###begin article-title 85
The codon 31 polymorphism of the p53-inducible gene p21 shows distinct differences between major ethnic groups.
###end article-title 85

